Gene · 23408
Papers2,327
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,327
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SIRT5: a potential target for discovering bioactive natural products. | J Nat Med | 2025 | 39979670 | PubTator, text mining | PubMed |
| SIRT5 Alleviated Eosinophilic Asthma Through ROS Inhibition and Nrf2/HO-1 Activation. | Inflammation | 2025 | 39946006 | PubTator, text mining | PubMed |
| CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness. | Anticancer Agents Med Chem | 2025 | 39945249 | PubTator, text mining | PubMed |
| Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development. | Front Immunol | 2025 | 39944690 | PubTator, text mining | PubMed |
| Sirtuin 5 Attenuates the Sepsis Induced Lung Injury via Modulation the Succinylation of Serine-Arginine Protein Kinase 1. | J Surg Res | 2025 | 39937563 | PubTator, text mining | PubMed |
| Moxibustion Alleviates Inflammation via SIRT5-mediated Post-translational Modification and Macrophage Polarization. | Inflammation | 2025 | 39899130 | PubTator, text mining | PubMed |
| Traversing the drug discovery landscape using native mass spectrometry. | Curr Opin Struct Biol | 2025 | 39893771 | PubTator, text mining | PubMed |
| SIRT5 -mediated desuccinylation of UQCRC2 attenuates osteogenic differentiation of aged BM-MSCs through impairing mitochondrial homeostasis. | Cell Signal | 2025 | 39892725 | PubTator, text mining | PubMed |
| The curious case of mitochondrial sirtuin in rewiring breast cancer metabolism: Mr Hyde or Dr Jekyll? | Biochim Biophys Acta Mol Basis Dis | 2025 | 39864670 | PubTator, text mining | PubMed |
| The SIRT5-JIP4 interaction promotes osteoclastogenesis by modulating RANKL-induced signaling transduction. | Cell Commun Signal | 2025 | 39810243 | PubTator, text mining | PubMed |
| [Corrigendum] Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1‑5 and increased expression of SIRT 6 and 7. | Int J Mol Med | 2025 | 39704217 | PubTator, text mining | PubMed |
| Electroacupuncture inhibits neuronal pyroptosis in ischemic brain injury through modulating SIRT5-mediated NEK7 succinylation. | Brain Res Bull | 2025 | 39694147 | PubTator, text mining | PubMed |
| PGC-1α Promotes mitochondrial biosynthesis and energy metabolism of goose fatty liver. | Poult Sci | 2025 | 39644719 | PubTator, text mining | PubMed |
| SIRT5 mediated succinylation of SUCLA2 regulates TCA cycle dysfunction and mitochondrial damage in pancreatic acinar cells in acute pancreatitis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39643219 | PubTator, text mining | PubMed |
| Buyang Huanwu Decoction restores the balance of mitochondrial dynamics after cerebral ischemia-reperfusion through calcium overload reduction by the PKCε-Nampt-Sirt5 axis. | J Ethnopharmacol | 2025 | 39528118 | PubTator, text mining | PubMed |
| Mechanism-based inactivators of sirtuin 5: A focused structure-activity relationship study. | Bioorg Med Chem Lett | 2025 | 39521149 | PubTator, text mining | PubMed |
| Lysine succinylation precisely controls normal erythropoiesis. | Haematologica | 2025 | 39415677 | PubTator, text mining | PubMed |
| Tetrandrine targeting SIRT5 exerts anti-melanoma properties via inducing ROS, ER stress, and blocked autophagy. | J Pharm Anal | 2024 | 39850232 | PubTator, text mining | PubMed |
| Molecular Sentinels: Unveiling the Role of Sirtuins in Prostate Cancer Progression. | Int J Mol Sci | 2024 | 39796040 | PubTator, text mining | PubMed |
| Sirtuin-5 Is Recruited to Hepatic Peroxisomes in Mice Fed Dodecanedioic Acid but Has Little Impact on the Peroxisomal Succinylome. | Biomolecules | 2024 | 39766215 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23408/papers?page=8